Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells

Specific changes in mucin-type O-glycosylation are common for many cancers, including gastric ones. The most typical alterations include incomplete synthesis of glycan structures, enhanced expression of truncated O-glycans (Tn, T antigens and their sialylated forms), and overexpression of fucosylati...

Descripción completa

Detalles Bibliográficos
Autores principales: Radziejewska, Iwona, Supruniuk, Katarzyna, Jakimiuk, Katarzyna, Tomczyk, Michał, Bielawska, Anna, Galicka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487805/
https://www.ncbi.nlm.nih.gov/pubmed/37685842
http://dx.doi.org/10.3390/ijms241713036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487805/
https://www.ncbi.nlm.nih.gov/pubmed/37685842
http://dx.doi.org/10.3390/ijms241713036

Ejemplares similares